Among 87,403 infertile women, IVF was not significantly associated with breast or gynecologic cancers. Among women receiving four or more cycles, ovarian cancer was nonsignificantly elevated, supporting further risk monitoring.
This preliminary study highlights the potential for nuclear magnetic resonance–based metabolite profiling of FF and blood plasma to examine changes across menstrual stages and in the pursuit of biomarkers to predict fertility treatment outcome.
The ethical considerations of providing fertility treatment to patients when the prognosis is very poor or futile are discussed.
IVM is an alternative to conventional IVF for women with polycystic ovaries. In vitro maturation avoids the risk of ovarian hyperstimulation syndrome but has a significantly lower live birth rate compared with IVF.
Although women were more likely to support IVF insurance coverage than men, there was a broad range of opinions addressing age, gender equality, reproductive choice, and economic equity and responsibility.
The author discusses the need to identify methods to minimize risk in IVF conceptions.
In a large cohort study, women with endometriosis associated infertility were found to have pregnancy and live birth rates similar to women with tubal factor infertility.
Fertility & Sterility Discussion Forums